Passiflora ligularis extract improved acetylcholinesterase activity, oxidative stress markers, and neurocognitive outcomes in scopolamine-induced Alzheimer's model in zebrafish
DOI:
https://doi.org/10.31989/ffhd.v15i7.1668Abstract
Background: Passiflora ligularis (granadilla) is known for its health benefits, including its potential in managing obesity. inflammation, and diabetes. This study aimed to evaluate the effects of an extract from P. ligularis fruit (PAS) o neuroinflammation, n cognitive function, and oxidative stress in a zebrafish model of scopolamine (SCO)-induced neurodegeneration.
Methods: Flavonoid profile was evaluated using high-performance liquid chromatography (HPLC-UV-MS). Zebrafish (Danio rerio) received oral PAS at dose of 4, 6, and 8 µg/ml or donepezil used as positive control (0.65 mg/kg) for 19 days, followed by SCO administration (100 µg/ml) one hour before behavioral tests. These included the novel tank diving test (NTT), Y-maze test, and novel object recognition test (NOR). Post-experiment biochemical brain parameters were analyzed.
Results: HPLC-UV-MS identified 11 phenolic compounds previously reported for their neuroprotective potential. PAS treatment significantly improved acetylcholinesterase (AChE) activity, oxidative stress markers, and neurocognitive impairments, demonstrating effects comparable to the donepezil group.
Conclusions: These findings suggest that Passiflora ligularis extract may be a promising phytotherapeutic approach for alleviating memory impairment and symptoms associated with Alzheimer’s disease.
Novelty of the study: This study investigates the effect of Passiflora ligularis extract on neurodegenerative disease in zebrafish model, revealing its potential to alleviate neurocognitive impairments mitigate neuroinflammation, reactive oxygen species and acetylcholinesterase.
Keyword: Passiflora ligularis; Alzheimer´s disease; neurodegenerative disease; oxidative stress
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Functional Foods in Health and Disease
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Any manuscripts or substantial parts of it, submitted to the journal must not be under consideration by or previously published in any other journal or citable form. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party. In submitting one's article in any form, the author has assigned the FFC publishing rights and has agreed to an automatic transfer of the copyright to the publisher. This is so that the FFC may create print option journals, for example, at the FFC’s discretion. If the author wishes to distribute their works by means outside of the FFC, for example within their community, they will have to place a request.
Correspondence concerning articles published in Functional Foods in Health and Disease is encouraged. While derivative works (adaptations, extensions on the current work, etc.) are allowed, distribution of the modified material is not allowed without permission from the FFC.